PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·PELOSI, NANCY BUYNVDA$500K–$1M·TUBERVILLE, TOMMY BUYMSFT$50K–$100K·CRENSHAW, DAN SELLXOM$15K–$50K·
← Leaderboard
KPTI
Ticker

KPTI

Congressional Trades
2
by 1 members
Buys
0
0%
Sells
2
100%
Total Volume
$16K
midpoint
Unique Traders
1
members

Party Breakdown

Democrats0 · 0%
Republicans2 · 100%

💼 Lobbying Filings

all →
  • 2026-04-20$0
    KARYOPHARM THERAPEUTICS
    Rare disease policy, drug approval process
  • 2026-01-20$100K
    KARYOPHARM THERAPEUTICS
    Rare disease policy, drug approval process
  • 2026-01-09$0
    KARYOPHARM THERAPEUTICS
    Rare disease policy, drug approval process
  • 2026-01-05$0
    KARYOPHARM THERAPEUTICS
    Rare disease policy, drug approval process

Congressional Momentum

buy vs. sell pressureDISTRIBUTING

Score 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.

Last 30 Days
No trades
Last 90 Days
No trades
All-Time
0
0 buys2 total2 sells
$0 buys · $16K sells

All Disclosed Trades

DateMemberActionAmountFiling Delay
2025-02-20RAshley MoodySELL$1K – $15K31d
2025-02-20RAshley MoodySELL$1K – $15K30d